Literature DB >> 3882026

Serotyping of Haemophilus pleuropneumoniae by rapid slide agglutination and indirect fluorescent antibody tests in swine.

V J Rapp, R F Ross, B Z Erickson.   

Abstract

One hundred and forty-one isolates of Haemophilus pleuropneumoniae from Iowa and Illinois swine were characterized morphologically and biochemically and serotyped by rapid slide agglutination (RSA) and indirect fluorescent antibody (IFA) tests. Hyperimmune antisera were produced in rabbits using inactivated whole-cell suspensions of the reference strains for H pleuropneumoniae serotypes 1 to 7 and strain 202, representing the taxon "minor group." Cross testing of the reference strains and reference antisera indicated the antisera to be essentially serotype-specific, although reactivity of some antisera with heterologous strains was observed. Cultures of the 141 isolates formed adherent or smooth colonies or mixtures of these colony forms. Adherent and smooth colony types were found in all serotypes identified. Microscopic and biochemical characteristics of all isolates were typical of those previously described for H pleuropneumoniae. The overall incidence of H pleuropneumoniae serotypes was serotype 5, 55.3%; serotype 1, 34.0%; serotype 7, 7.8%; and nontypeable, 2.8%. Comparing the 2 test procedures, 87.2% of the isolates could be typed by RSA, and 66.0% could be typed by IFA. Cross-reactions between serotype 4 antisera and serotype 5 and 7 isolates were common with the IFA test. The reactions with serotype 7, but not serotype 5, were eliminated by cross adsorption of serotype 4 antisera. There was good correlation between the 2 test procedures, but RSA was judged to be more specific and sensitive than IFA.

Entities:  

Mesh:

Year:  1985        PMID: 3882026

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  18 in total

1.  Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumonia in pigs.

Authors:  E M Kamp; N Stockhofe-Zurwieden; L A van Leengoed; M A Smits
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Cross-reactivity and antigenic heterogeneity among Actinobacillus pleuropneumoniae strains of serotypes 4 and 7.

Authors:  K R Mittal; S Bourdon
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

3.  Detection of serotype-specific antibodies or capsular antigen of Actinobacillus pleuropneumoniae by a double-label radioimmunoassay.

Authors:  T J Inzana; G F Clark; J Todd
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Analysis of southern Ontario Actinobacillus (Haemophilus) pleuropneumoniae isolates by restriction endonuclease fingerprinting.

Authors:  J I MacInnes; J D Borr; M Massoudi; S Rosendal
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

5.  Hemolysin patterns of Actinobacillus pleuropneumoniae.

Authors:  J Frey; J Nicolet
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Outer membrane protein profiles of Haemophilus pleuropneumoniae.

Authors:  V J Rapp; R S Munson; R F Ross
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Microorganisms associated with pneumonia in slaughter weight swine.

Authors:  R B Morrison; C Pijoan; H D Hilley; V Rapp
Journal:  Can J Comp Med       Date:  1985-04

8.  Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infection.

Authors:  V J Rapp; R F Ross
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

9.  Characterization of Haemophilus spp. isolated from healthy swine and evaluation of cross-reactivity of complement-fixing antibodies to Haemophilus pleuropneumoniae and Haemophilus taxon "minor group".

Authors:  V J Rapp; R F Ross; T F Young
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

10.  Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.